Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies (Details Textual)

v3.10.0.1
Commitments and Contingencies (Details Textual)
 1 Months Ended 12 Months Ended
Jul. 09, 2015
USD ($)
Sep. 12, 2013
USD ($)
Feb. 21, 2017
USD ($)
Jun. 17, 2016
USD ($)
Feb. 15, 1999
USD ($)
Dec. 31, 2018
USD ($)
ft²
Dec. 31, 2017
USD ($)
Dec. 31, 2019
USD ($)
Sep. 26, 2018
USD ($)
Jul. 06, 2016
ft²
Commitments and Contingencies [Line Items]                    
Area of Land | ft²                   2,300
Payments to Acquire Intangible Assets           $ 250,000 $ 0      
Lease Expiration Period         12 years          
Payment of annual fee   $ 30,000                
Contract with Customer, Liability, Revenue Recognized           9,627,600        
Intangible Assets, Net (Excluding Goodwill)           $ 4,156,064 $ 3,912,314      
Additional Milestones to be Met and Due         $ 150,000          
License [Member]                    
Commitments and Contingencies [Line Items]                    
Cost of Goods and Services Sold   $ 50,000   $ 15,000 12,500          
Subsequent Event [Member]                    
Commitments and Contingencies [Line Items]                    
Operating Leases, Future Minimum Payments Due               $ 144,000    
Minimum [Member] | License [Member]                    
Commitments and Contingencies [Line Items]                    
Cost of Goods and Services Sold       5,000            
Maximum [Member] | License [Member]                    
Commitments and Contingencies [Line Items]                    
Cost of Goods and Services Sold       $ 20,000            
New Valeant Agreement [Member]                    
Commitments and Contingencies [Line Items]                    
Revenues Recognition Milestone Method Description     the Company was eligible to receive milestone payments totaling up to approximately $99.0 million, upon and subject to the achievement of certain specified developmental and commercial progress of the EGP-437 Combination Product for the New Field.              
Proceeds From Upfront Payment     $ 4,000,000              
Contract with Customer, Liability, Revenue Recognized     $ 99,000,000              
Licensor [Member]                    
Commitments and Contingencies [Line Items]                    
Area of Land | ft²           4,516        
Valeant Pharmaceuticals International Inc [Member] | Licensing Agreements [Member]                    
Commitments and Contingencies [Line Items]                    
Payments to Acquire Intangible Assets $ 1,000,000                  
Proceeds from Sale of Intangible Assets $ 32,500,000                  
SentrX Animal Care Inc [Member]                    
Commitments and Contingencies [Line Items]                    
Payment of annual fee         $ 30,000          
Intangible Assets, Net (Excluding Goodwill)           $ 250,000     $ 250,000  
Intangible Assets Expected Milestone Payable           $ 4,750,000     $ 4,750,000